The NIH may own intellectual property that undergirds a leading coronavirus vaccine being developed by Moderna, according to documents obtained by Axios and an analysis from Public Citizen. Why it matters: Because the federal government has an actual stake in this vaccine, it could try to make the vaccine a free or low-cost public good with wide distribution, if the product turns out to be safe and effective. The big picture: The NIH rarely claims ownership stakes or pursues patent rights, but that appears to be different with this coronavirus vaccine. Earlier this year NIH Director Collins noted “We do have some particular stake in the intellectual property” behind Moderna’s coronavirus vaccine. Learn More